All In Biotech

Drug Trial Radar · NCT05719467

SAINT: Safe Induction of Labor Trial

A Double-blind Randomized Placebo-controlled Four-arm Trial to Assess the Efficacy of Oral Bicarbonate and Intravenous Butylscopolamine Bromide to Facilitate Spontaneous (Non-operative) Delivery in Pregnant Female Participants With Induction of Labor

Last checked: Nov 20, 2026Latest source record: Apr 4, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 3,000 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

3,000

Planned (sponsor's estimate)

Start

Jan 3, 2023

Primary completion

Jan 31, 2025

Study completion Dec 31, 2027

Sponsor

Lead sponsor
Oslo University HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Feb 9, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Female only, from 18 years, up to 50 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Over the past years, the rates of labor induction have increased steadily, and at present more than one in four births occurs after induced labor in Norway. There is evidence that several groups of women benefit from labor induction, including those with preeclampsia (1), postdate pregnancy, diabetes, a large-for-gestational-age fetus, gestational diabetes, prelabor rupture of membranes at term, preterm prelabor rupture of membranes, twin pregnancy and intrahepatic cholestasis of pregnancy. At the same time, induction of labor is an independent risk factor for adverse obstetric outcomes, including cesarean section, operative vaginal delivery, chorioamnionitis, labor dystocia, prolonged labor, uterine rupture, and neonatal pH \< 7.10. A recent Norwegian nationwide clinical practice pilot evaluation demonstrated that the rate of intervention was high, and that as many as 44% of women with labor induction experienced operative delivery. Given that induction of labor is a common procedure (15 000 women per year in Norway) and increases risk of several major obstetric complications, interventions that may reduce operative births and facilitate safe deliveries are highly warranted. Bicarbonate and butylscopolamine bromide have been used in smaller studies in order to shorten labor. The medications seem to be safe with a low frequency of adverse events. The rationale of the present study is therefore to assess the efficacy of oral bicarbonate and intravenous butylscopolamine bromide on facilitating spontaneous (non-operative) delivery in pregnant female participants with induction of labor.

Conditions

  • Labor Complication
  • Induced; Birth
  • Pregnancy Related

Interventions

  • Buscopan 20 MG/ML Injectable SolutionDrug

    1 mL intravenously

  • Sodium bicarbonateDrug

    4 g orally

  • PlaceboDrug

    4g orally

  • Nacl 0.9%Drug

    1 mL intravenously

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Spontaneous vs operative birthTime frame: Through study completion, an average of one week

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Akershus University Hospital

    Lørenskog, Norway · Recruiting

  • Oslo University Hospital Rikshospitalet

    Oslo, Norway · Recruiting

  • Oslo University Hospital Ullevål

    Oslo, Norway · Recruiting

  • Stavanger University Hospital

    Stavanger, Norway · Recruiting

  • The University Hospital of North Norway

    Tromsø, Norway · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.